This webinar titled “Hot Topics in CNS for MRI” discusses practice gaps in the value of high relaxivity for brain cancer detection and evaluation and its possible impact in patient treatment decision-making. In addition, we discuss properties of available GBCAs and how they selectively matter in the selection of an MR contrast agent in neuroradiology. The purpose of this webinar is to provide physicians, technologists, and other health care professionals with current clinical data to make informed decisions in their clinical settings.
- Describe properties of available GBCAs and how they selectively matter in the selection of an MR contrast agent in
- Discuss the value of high relaxivity for brain cancer detection and evaluation and possible impact in patient treatment decision-making.
- Identify gadolinium exposure: which dose to use in which population including patients with lifetime risk of multiple repeated injections g., MS patients and patients for tumor diagnosis and follow-up and at which field strength.
- Review safety of GBCAs: perceived vs real differences
- Discuss the future of MRI: new agents and new technology (e.g., A.I.) on the horizon
The content of this CME/CE live symposium is intended for healthcare professionals including Radiologists and Other Physicians, Technologists, Radiologic and Imaging Nurses, Facility Managers, Researchers, and others.
This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). Northwest Imaging Forums (NWIF) is accredited by the ACCME to provide continuing medical education for physicians. NWIF designates this webinar for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release Date: 09/03/2022 | Expires 09/02/2023
Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any relevant financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CME activity. The planner has nothing to disclose.
Max Wintermark, MD
Chairman of Neuroradiology University of Texas-MD Anderson
Houston, Texas
Howard A. Rowley, MD
Joseph Sackett Professor,
Radiology Professor, Radiology,
Neurology, and Neurosurgery University of Wisconsin Madison, Wisconsin